Switch to
More onapp

How to use scorecard? Learn more

GlaxoSmithKline Pharmaceuticals Ltd

GLAXO
Health CarePharmaceuticals
MidcapWith a market cap of ₹36,373 cr, stock is ranked 200
Moderate RiskStock is 2.47x as volatile as Nifty
2,147.1026.55 (-1.22%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹36,373 cr, stock is ranked 200
Moderate RiskStock is 2.47x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
68.77
PB RatioPB Ratio
20.89
Dividend YieldDiv. Yield
1.49%
Sector PESector PE
51.38
Sector PBSector PB
5.89
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

25%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20202021202220233.853.144.703.370.090.361.690.61
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss/Duplicate-Share Certificate-XBRL 
Announced OnFeb 27, 2024

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Loss of share certificates | Download

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Loss of share certificates | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnFeb 23, 2024

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Loss of share certificates | Download

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Loss of share certificates | Download

Cash Dividend 
Ex. DateJun 30, 2023

Final • Div/Share: ₹ 32

See all events